Iron and pathophysiology: From basic mechanisms to clinical translation
our research
Unique biochemical properties underpin the essential functions of iron in oxygen transport and oxidative phosphorylation. Those same properties also underpin its propensity to participate in Fenton-type reactions, producing cell-damaging reactive oxygen species. Thus, tight control of iron levels within tissues is paramount for normal physiological function, particularly in tissues of high oxygen demand/flux.
Our research focusses on understanding the impact of too little or too much iron on the cardiovascular system, and on translating that understanding into better management of iron status in cardiovascular disorders. Examples of our recent translational work include:
Discovering the impact of intravenous iron therapies on iron levels in different tissues
- Vera-Aviles, M., Kabir, S. N., Shah, A., Polzella, P., Lim, D. Y., Buckley, P., Ball, C., Swinkels, D., Matlung, H., Blans, C., Holdship, P., Nugent, J., Anderson, E., Desborough, M., Piechnik, S., Ferreira, V., & Lakhal-Littleton, S✉. (2024). Intravenous iron therapy results in rapid and sustained rise in myocardial iron content through a novel pathway. European heart journal, 45(42), 4497–4508. https://doi.org/10.1093/eurheartj/ehae359 *This work was highlighted in a special issue by the editor https://doi.org/10.1093/eurheartj/ehae752 and an accompanying editorial was invited https://doi.org/10.1093/eurheartj/ehae560.
- Piechnik, S. K., Polzella, P., Shah, A., Vera-Aviles, M., Kabir, S. N., Desborough, M., Ferreira, V. M., & Lakhal-Littleton, S✉. (2025). Myocardial iron intake following intravenous iron therapy with ferric carboxymaltose is sustained at 1 year despite recurrence of iron deficiency. British journal of haematology, 206(1), 349–352. https://doi.org/10.1111/bjh.19915
Placing basic discoveries into clinical context;
- Lakhal-Littleton, S✉., & Cleland, J. G. F. (2024). Iron deficiency and supplementation in heart failure. Nature reviews. Cardiology, 21(7), 463–486. https://doi.org/10.1038/s41569-024-00988-1
- Lakhal-Littleton S✉. (2025). Anaemia, neurohormonal activation, and myocardial iron depletion in heart failure: can this vicious circle be broken?. European heart journal, 46(16), 1524–1527. https://doi.org/10.1093/eurheartj/ehae798
- Lakhal-Littleton, S✉., (2025) Iron deficiency in heart failure. Iron in Clinical Practice. edited by Sue Pavord and Noemi Roy. ISBN: 978-1-394-21090-9. https://www.wiley.com/en-us/Iron+in+Clinical+Practice-p-9781394210909
- Cleland, J. G. F., Pellicori, P., & Lakhal-Littleton, S. (2024). Low Serum Ferritin Might Predict Incident Heart Failure: But Why and Is It Clinically Useful?. JACC. Heart failure, 12(3), 549–551. https://doi.org/10.1016/j.jchf.2023.12.01
Revealing the impact of inflammation on spleen iron trapping after intravenous iron therapy
- Nunez, J., Mollar, A., Vera-Aviles, M., Kabir, S., Shah, A., Polzella, P., Desborough, M., Cardells, I., Miñana, G., Del Canto, I., Ferreira, V., Piechnik, S., Maceira, A., & Lakhal-Littleton, S✉. (2025). Baseline serum ferritin predicts myocardial iron uptake following intravenous iron therapy - a hypothesis-generating study. European journal of heart failure, 10.1002/ejhf.3730. Advance online publication. https://doi.org/10.1002/ejhf.3730
Mechanistically defining the impact of iron status on long-term outcomes of myocardial infarction
- Vera-Aviles, M., Kabir, S.N., Christodoulou, M.D., Shanmuganathan, M., Kotronias, R., Cleland, J.G.F., OxAMI investigators, Channon, K.M., Lakhal-Littleton, S✉.(2025) Hypoferremia reduces long-term risk of major adverse cardiovascular events after STEMI by averting the myocardial reactive iron storm. medRxiv 2025.01.13.25320244; doi: https://doi.org/10.1101/2025.01.13.25320244
Related research themes
We use the full range of modern molecular genetic ...
We are recognised internationally for our ...
We study everything from the structure of ion ...